UC BRAID

Celebrating ten years of shared infrastructure and programs that accelerate research and improve health, UC BRAID convened its annual meeting on October 14-15, 2019 at the UCLA Luskin Conference Center. UC BRAID, the University of California Biomedical Research Acceleration, Integration, & Development, is a consortium of the five UC academic medical centers—Davis, Irvine, Los Angeles, San Diego and San Francisco.

via UC Newsroom

The University of California announced today (July 19) that Laurie Herraiz has

accepted the position of executive director of UC BRAID (Biomedical Research Acceleration, Integration, and Development).

Advancing the next generation of health research: Are we future-ready?

The 2018 UC BRAID Retreat generated exciting ideas and opportunities to network with colleagues across the UC system. Participants engaged in cross-discipline roundtables focused on preparing for new recruitment strategies, study designs, and health technology and data. We also heard updates on innovative cross-UC collaborations and shared resources. 

Please take a moment to review the 2018 Retreat resources below: 

Having developed a powerful health research collaboration across five University of California medical campuses, the leaders of UC BRAID have a new strategic focus: the integration of research and clinical care to create a learning health ecosystem where patient information and data are continuously analyzed to provide individualized care.

UC BRAID Highlights 2016-17 Accomplishments

In advance of its annual retreat later this month, the University of California Biomedical Research Acceleration, Integration and Development (UC BRAID) reported its accomplishments over the past year. A consortium of five UC medical campuses with Clinical and Translational Science Awards (CTSAs), UC BRAID streamlines administrative processes to accelerate research to improve health.

Note: The consortium brings together UC's five medical center campuses — Davis, Irvine, Los Angeles, San Diego and San Francisco — to share resources and expertise to help develop new drugs.

By Alec Rosenberg via UC Newsroom